Displaying 10 out of 26 results

  1. A logo is seen in front of the entrance at the headquarters of French drugmaker Sanofi in Paris

    Sanofi, Regeneron lose US patent challenge to Amgen cholesterol drug

    A U.S. jury on Monday said patents owned by Amgen Inc on its cholesterol drug Rapatha are valid, rejecting a challenge by Regeneron ...
  2. FILE PHOTO: File photo of an Amgen sign at the company's office in South San Francisco

    Amgen quarterly profit tops Street view, 2019 forecast falls short

    Amgen Inc on Tuesday reported higher-than-expected fourth-quarter profit as sales rose and tax expense fell, but competition for older medicines ...
  3. FILE PHOTO - A CVS Pharmacy store is seen in the Manhattan borough of New York City

    Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen

    CVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to ...
  4. FILE PHOTO: File photo of an Amgen sign at the company's office in South San Francisco

    Amgen's postmenopausal osteoporosis drug wins FDA panel backing

    An advisory panel to the U.S. Food and Drug Administration on Wednesday recommended Amgen Inc's osteoporosis treatment for postmenopausal women at ...
  5. Workers of Teva Pharmaceutical Industries stand at the entrance to their facility in Ashdod, Israel

    Teva, Amgen end dispute over generic Cinacalcet HCl tablets

    Teva Pharmaceutical Industries Ltd said on Thursday it will pay an undisclosed amount to settle an ongoing dispute with Amgen Inc over its ...
  6. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Amgen, Novartis kick off fight for AbbVie blockbuster drug in EU

  7. NYSE Aug 10

    US stocks tumble on North Korea worries

  8. NYSE 400

    US stocks pressured by trade-war worries

    Wall Street stocks finished modestly lower on Friday (Mar 17) as worries about international trade hung over the first meeting between President ...
  9. New Content Item

    Weak earnings, Trump fears pressure US stocks

    The Dow retreated on Tuesday as US stocks remained pressured following lacklustre earnings from ExxonMobil and uncertainty over the Trump growth ...